Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Cyclosporin A and tacrolimus reduce T-cell polyfunctionality but not interferon-γ responses directed at cytomegalovirus.

Fuhrmann S, Lachmann R, Streitz M, Hetzer R, Volk HD, Lehmkuhl H, Kern F.

Immunology. 2012 Aug;136(4):408-13. doi: 10.1111/j.1365-2567.2012.03594.x.

2.

Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.

Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.

Cytometry B Clin Cytom. 2008 Jul;74(4):211-20. doi: 10.1002/cyto.b.20420.

3.

Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment.

Engstrand M, Lidehall AK, Totterman TH, Herrman B, Eriksson BM, Korsgren O.

Clin Exp Immunol. 2003 Apr;132(1):96-104.

4.

Maintenance of CMV-specific CD8+ T cell responses and the relationship of IL-27 to IFN-γ levels with aging.

Shin MS, Lee JS, Lee N, Lee WW, Kim SH, Kang I.

Cytokine. 2013 Feb;61(2):485-90. doi: 10.1016/j.cyto.2012.11.024. Epub 2012 Dec 29.

5.

Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.

Ahmed M, Venkataraman R, Logar AJ, Rao AS, Bartley GP, Robert K, Dodson FS, Shapiro R, Fung JJ, Zeevi A.

Ther Drug Monit. 2001 Aug;23(4):354-62.

PMID:
11477316
6.

Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.

Egli A, Binet I, Binggeli S, Jäger C, Dumoulin A, Schaub S, Steiger J, Sester U, Sester M, Hirsch HH.

J Transl Med. 2008 Jun 9;6:29. doi: 10.1186/1479-5876-6-29.

7.

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.

Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F.

J Exp Med. 2005 Apr 4;201(7):1031-6. Epub 2005 Mar 28.

8.

Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.

Clari MÁ, Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, Bravo D, Amat P, Navarro D.

Clin Vaccine Immunol. 2012 May;19(5):791-6. doi: 10.1128/CVI.05633-11. Epub 2012 Feb 29.

9.

Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children.

Tu W, Chen S, Sharp M, Dekker C, Manganello AM, Tongson EC, Maecker HT, Holmes TH, Wang Z, Kemble G, Adler S, Arvin A, Lewis DB.

J Immunol. 2004 Mar 1;172(5):3260-7.

10.

Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.

Shlobin OA, West EE, Lechtzin N, Miller SM, Borja M, Orens JB, Dropulic LK, McDyer JF.

J Immunol. 2006 Feb 15;176(4):2625-34.

11.

High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.

Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.

Transpl Immunol. 2009 Mar;20(4):238-42. doi: 10.1016/j.trim.2008.11.002. Epub 2008 Nov 24.

PMID:
19032982
12.

Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.

Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF.

J Infect Dis. 2011 Dec 1;204(11):1663-71. doi: 10.1093/infdis/jir624. Epub 2011 Oct 21.

13.

Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.

Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA; Studies of Ocular Complications of AIDS Research Group.

J Infect Dis. 2006 Dec 1;194(11):1537-46. Epub 2006 Oct 26.

14.

Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.

Lilleri D, Zelini P, Fornara C, Comolli G, Revello MG, Gerna G.

Clin Immunol. 2009 Jun;131(3):395-403. doi: 10.1016/j.clim.2009.02.002. Epub 2009 Mar 5.

PMID:
19268633
15.

Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.

Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Bravo D, Clari MÁ, Navarro D.

J Med Virol. 2012 Feb;84(2):259-67. doi: 10.1002/jmv.22254.

PMID:
22170546
16.

A polymorphism linked to elevated levels of interferon-γ is associated with an increased risk of cytomegalovirus disease among Caucasian lung transplant recipients at a single center.

Mitsani D, Nguyen MH, Girnita DM, Spichty K, Kwak EJ, Silveira FP, Toyoda Y, Pilewski JM, Crespo M, Bhama JK, Abdel-Massih R, Zaldonis D, Zeevi A, Clancy CJ.

J Heart Lung Transplant. 2011 May;30(5):523-9. doi: 10.1016/j.healun.2010.11.008. Epub 2011 Jan 15.

PMID:
21239188
17.

Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.

Couzi L, Thiébaut R, Carron JC, Moreau JF, Merville P, Taupin JL.

Transplantation. 2008 Oct 27;86(8):1060-7. doi: 10.1097/TP.0b013e31818758e4.

PMID:
18946343
18.

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.

Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro D.

Bone Marrow Transplant. 2011 Nov;46(11):1437-43. doi: 10.1038/bmt.2010.330. Epub 2011 Jan 17.

PMID:
21243030
19.

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.

J Infect Dis. 2001 Aug 1;184(3):256-67. Epub 2001 Jul 10.

20.

Suppression of cytomegalovirus-specific CD8(+)T cells by everolimus.

Jin N, Malcherek G, Mani J, Zurleit R, Schmitt A, Chen B, Freund M, Ho AD, Schmitt M.

Leuk Lymphoma. 2014 May;55(5):1144-50. doi: 10.3109/10428194.2013.822496. Epub 2013 Aug 31.

PMID:
23841510
Items per page

Supplemental Content

Write to the Help Desk